Cayenne Pepper Cataplasm - Safety Study
Klíčová slova
Abstraktní
Popis
Musculoskeletal diseases, such as neck and low back pain, are widespread disorders in many developed countries. Their management is challenging, and it may have mounting socioeconomic burden. Several evidences in the literature demonstrate the efficacy of many therapeutic strategies in the treatment of these conditions, based on pharmacological or surgical interventions. Physical medicine therapies are good alternatives that may have beneficial effects, especially when used as first line of intervention before approaching more expensive pharmacological or invasive medications. The beneficial analgesic effects of Applicatio Epispasticorum of Rubefacenciae (redden skin substances), is known since 1830 as a treatment for pain, cramps, and disorders of the musculoskeletal system. Herbal cataplasms containing rubefacient substances, such as Cayenne pepper (CP), are commonly used as natural medications to treat painful or aching areas in the case of acute or chronic back pain, and rheumatisms. They are also used in pain involving joints caused by osteoarthritis. A galenic preparation composed of rubefacient substances of vegetable origin, which generated vasodilation and increase in blood circulation on the treated areas, was first prescribed in 1909 by Dr. Giuseppe Munari to treat pain of various areas of the locomotive system. He proposed a method based on applications prepared according to his own galenic formula that have become famous all over Italy and Europe. In Vienna and lower Austria, a Munari-like application containing CP and Kaolin powder in mixed proportion, is commonly used to treat musculoskeletal conditions of pain especially of the low back. The research on responses to CPC applications, particularly in combination with other modalities is scarce.
Therefore, the aims of the present study are firstly to evaluate the effects of 10x 20min CP cataplasm application on selected functional and molecular parameters on healthy subjects. Then, the same applications will be used on subjects suffering from low back pain (LBP) - both as a single treatment and in combination with electrical stimulation and massage.
Termíny
Poslední ověření: | 01/31/2018 |
První předloženo: | 02/05/2018 |
Odhadovaná registrace vložena: | 02/18/2018 |
První zveřejnění: | 02/19/2018 |
Poslední aktualizace byla odeslána: | 02/18/2018 |
Poslední aktualizace zveřejněna: | 02/19/2018 |
Aktuální datum zahájení studie: | 03/14/2016 |
Odhadované datum dokončení primární: | 11/14/2016 |
Odhadované datum dokončení studie: | 12/14/2016 |
Stav nebo nemoc
Intervence / léčba
Drug: Cayenne Pepper topical
Device: LBP patients - CPC and ES/M Group
Procedure: LBP patients - CPC and ES/M Group
Fáze
Skupiny zbraní
Paže | Intervence / léčba |
---|---|
Experimental: Healthy Healthy participants with no low back pain. 20 min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical) on the back will be administered. | |
Experimental: LBP patients - CPC Group Participants suffering from low back pain (LBP) receiving 10 times (within 3 weeks) 20min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical). | |
Experimental: LBP patients - CPC and ES/M Group Participants suffering from low back pain (LBP) receiving 10 times (within 3 weeks) 20min application of Cayenne Pepper Cataplasm (Cayenne Pepper topical), and half of the subject also receiving 10 min electrical Stimulation and 10 min massage Treatment on the back. | Device: LBP patients - CPC and ES/M Group Electrical stimulation 10min 60Hz biphasic rectangular neuromuscular electrical Stimulation (NMES) |
Kritéria způsobilosti
Věky způsobilé ke studiu | 18 Years Na 18 Years |
Pohlaví způsobilá ke studiu | All |
Přijímá zdravé dobrovolníky | Ano |
Kritéria | Inclusion Criteria: - Chronic low back pain (>3 months) - Body mass index below 35 kg/mˇ2 Exclusion Criteria: - pregnancy - sensibility disorders (e.g. due to neurological disease) - injuries, open wounds or rash in intervention area - known hypersensitivity against the applied substances - HIV, Hepatitis C and other due blood communicable infectious diseases |
Výsledek
Primární výsledná opatření
1. Change in concentration of circulating biomarkers of inflammation, neudroendocrine stress and blood vessel activation [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
2. Change in systolic and diastolic blood pressure [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
3. Heart rate [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
Měření sekundárních výsledků
1. 36-Item Short Form Survey (SF-36) [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
2. Change in pain perception [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
3. EQ-5D- 5L questionnaire [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
4. Oswestry disability index (ODI) [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
5. Skin Sensory Function [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
6. Flexibility [Before the application, 45 minutes after 10th application and 48 hours after 10th application]
7. Skin Temperature [Before the application, 45 minutes after 10th application and 48 hours after 10th application]